Parse Biosciences secures $50m in Series C for single cell sequencing
Parse Biosciences has announced a significant milestone in their funding journey, securing a total of $50 million through a Series C equity raise and a debt facility. This round of financing was led by Soleus Capital and witnessed participation from several new and existing investors such as Bioeconomy Capital, Janus Henderson Investors, Marshall Wace, Sahsen […]